306: Integrative Approach to Neurodevelopmental Disorders

This course is designed to assist health care professionals in understanding how, when and what types of integrative neurodevelopmental approaches might be paired with conventional therapies to enhance pediatric care throughout the range of pediatric ages and developmental stages. Effective treatment of neurodevelopmental disorders, especially ADHD and autism, is necessary for the growing number of children and adolescents suffering from these illnesses, but a comprehensive, integrative approach is not emphasized in pediatric medical education.

This course will help to close this knowledge gap and assist health care professionals in understanding how, when and what types of integrative medicine approaches and interventions to neurodevelopmental disorders might be used in conjunction with conventional therapies to enhance pediatric care. This is important because an accruing number of effective, safe, non-pharmaceutical therapies are available for children yet not widely known or taught to clinicians.

Accreditation / Credit Designation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Arizona College of Medicine – Tucson and Academy of Pediatric Integrative Medicine. The University of Arizona College of Medicine – Tucson is accredited by the ACCME to provide continuing medical education for physicians.

The University of Arizona College of Medicine – Tucson designates this enduring material for a maximum of 7.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Outcome Objectives

1. Identify pediatric patients that could potentially benefit from integrative medicine neurodevelopmental disorders treatment options.
2. Determine which medical conditions have robust supporting evidence for the use of neurodevelopmental disorders integrative medicine treatment options in children.
3. Teach clinicians how to better educate parents about neurodevelopmental disorders integrative medicine treatment options for their children.

Current CME Approval Period: 7/31/2026 – 8/1/2028

Date of Most Recent Review: July 2026

Relevant Financial Relationships Statement

University of Arizona College of Medicine – Tucson Office of Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). The CME office reviewers have nothing to disclose. All relevant financial relationships have been mitigated prior to the commencement of the activity.

All individuals in a position to control the content of this CME activity have disclosed that they have no relevant financial relationships with ineligible companies that would constitute a conflict of interest concerning this CME activity.